Renafor-B Inhaler is a high-strength combination inhaler containing Budesonide 160 mcg and Formoterol Fumarate 4.5 mcg per puff. It is designed for the long-term management of moderate to severe asthma and chronic obstructive pulmonary disease (COPD). This inhaler combines the anti-inflammatory effects of Budesonide with the long-acting bronchodilation of Formoterol to provide comprehensive control of chronic respiratory conditions.

• Budesonide, an inhaled corticosteroid, reduces airway inflammation, swelling, and mucus production, preventing flare-ups and long-term airway damage.

• Formoterol Fumarate, a long-acting beta-2 adrenergic agonist (LABA), relaxes bronchial smooth muscles, improving airflow and easing breathing.

Renafor-B Inhaler 160/4.5 mcg is particularly suited for patients who require stronger anti-inflammatory control due to persistent or severe symptoms, helping to reduce exacerbations, improve lung function, and enhance quality of life.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each puff of Renafor-B Inhaler contains:

• Budesonide – 160 mcg

• Formoterol Fumarate – 4.5 mcg

Mechanism of Action

Renafor-B Inhaler works through the complementary actions of its two active ingredients:

• Budesonide: Suppresses airway inflammation by inhibiting inflammatory cells and mediators, reducing swelling and mucus formation.

• Formoterol Fumarate: Stimulates beta-2 adrenergic receptors in airway smooth muscles, producing long-lasting bronchodilation and improving airflow.

This combination ensures both symptom relief and prevention of asthma or COPD exacerbations.

Indications

Renafor-B Inhaler 160/4.5 mcg is indicated for:

• Moderate to severe persistent asthma requiring daily maintenance therapy

• Chronic Obstructive Pulmonary Disease (COPD) with persistent symptoms

• Patients who have frequent exacerbations despite lower-dose therapy

• Long-term prevention of airway obstruction and inflammation

This inhaler is intended for maintenance therapy and is not suitable as a rescue inhaler for sudden attacks.

Dosage and Administration

The exact dosage should be determined by a healthcare professional. General guidelines include:

• Typical dose: 1 puff twice daily, or as prescribed by a physician

• Shake the inhaler well before use

• Exhale completely, place the mouthpiece in the mouth, and inhale deeply while pressing the canister

• Hold the breath for 5–10 seconds, then exhale slowly

• Rinse the mouth with water after use to prevent oral thrush caused by Budesonide

Consistency is crucial for effective control of chronic respiratory symptoms.

Possible Side Effects

Common side effects may include:

• Throat irritation or hoarseness

• Cough

• Dry mouth

• Mild tremors or palpitations

• Headache

Less common but serious side effects may include:

• Increased heart rate

• Severe allergic reactions

• Worsening respiratory symptoms

Patients should seek medical attention if severe or persistent symptoms occur.

Precautions and Warnings

• Inform your doctor about heart disease, high blood pressure, or arrhythmias

• Use with caution in patients with diabetes, thyroid disorders, or seizure disorders

• Not suitable as a rescue inhaler; always have a short-acting inhaler for sudden attacks

• Regular monitoring of lung function may be necessary

Use in Pregnancy and Lactation

Renafor-B Inhaler should only be used during pregnancy or breastfeeding if clearly necessary and prescribed by a healthcare provider. The benefits and risks should be carefully weighed.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 30°C in a dry place

• Keep the inhaler upright and protected from direct sunlight

• Keep out of reach of children

Conclusion

Renafor-B Inhaler 160/4.5 mcg (Budesonide + Formoterol Fumarate) is a high-strength inhaler for long-term management of moderate to severe asthma and COPD. By combining anti-inflammatory and bronchodilator effects, it helps prevent exacerbations, improve breathing, and enhance quality of life. Proper use under medical supervision ensures safe and effective control of chronic respiratory conditions.